Beruflich Dokumente
Kultur Dokumente
i
Losartan Indications/Dosage. Clinical Pharmacology. 2009.
ii
Akinboboye O, Chou R, Bermann S. Augmentation of myocardial blood flow in hypertensive heart
disease by angiotensin antagonists. Journal of the American College of Cardiology. 2002;(40)4:705-709.
iii
Valsartan Indications/Dosage. Clinical Pharmacology. 2009.
iv
Benz J, Oshrain C, Henry D, Avery C, et al. Valsartan, a new angiotensin II receptor antagonist: A
double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. Journal of
Clinical Pharmacology. 1997;(37)2:101-107.
v
De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, et al. Comparison of the effect of
valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. American Heart
Journal. 2003; (5):E17.
vi
Menne J, Farsang C, Dek L, Klebs S, Meier M, Handrock R, et al. Valsartan in combination with lisinopril
versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the
VALERIA trial. Journal Of Hypertension. 2008;(9)1860-7.
vii
Lisinopril Indications/Dosage. Clinical Pharmacology. 2009.
viii
Hunt SA, Abraham WT, Chin MH et al. ACC/AHA Guideline Update for the Diagnosis and Management of
Chronic Heart Failure in the Adult. J Am Coll Cardiol. 2005 Sep 20;46(6):e182.